Log in  First Connection?

LungArchives

LUMINATE-101-Maccabi: a real-world study of treatment patterns and clinical outcomes in patients with non-squamous metastatic non-small cell lung cancer in an Israeli Health Maintenance Organization (HMO)
Lung
 1 min.

 Published on 26/05/2026 |  Original article (Full-text)  | Sarah Sharman Moser et al. | Expert Review of Anticancer Therapy 2026; aop:10.1080/14737140.2026.2671251

Treatment options for non-small cell lung cancer (NSCLC) patients lacking actionable genetic alterations (non-AGA) remain limited, particularly after first-line (1L) therapy. This study evaluated real-world treatment patterns and outcomes among second or later-line (2L+) patients with non-AGA non-squamous...

Complications following small-molecule inhibitors for non-small cell lung cancer
Lung
 1 min.

 Published on 19/05/2026 |  Original article (Full-text)  | Caroline Kamali et al. | Expert Review of Anticancer Therapy 2026; aop:10.1080/14737140.2026.2665836

Targeted therapies for oncogene-driven non–small cell lung cancer (NSCLC) have transformed precision oncology by enabling treatment tailored to specific molecular alterations and substantially improving outcomes in advanced disease. However, these agents are associated with distinct patterns of...

Pembrolizumab trough concentration monitoring and association with outcomes in advanced non-small cell lung cancer
Lung
 1 min.

 Published on 12/05/2026 |  Original article (Full-text)  | Ioannis P. Trontzas et al. | Expert Review of Anticancer Therapy 2026; aop:10.1080/14737140.2026.2668466

Therapeutic drug monitoring (TDM) of immune checkpoint inhibitors (ICIs) remains limited due to drug-related challenges; however, a better understanding of exposure–effect relationships may improve antitumor activity and reduce immune-related adverse events (irAEs). We conducted a prospective TDM...

Sex-based differences in effectiveness of immune checkpoint inhibitors in the treatment of advanced non-small-cell lung cancer: systematic review and meta-analysis
Lung
 7 min.

 Published on 05/05/2026 |  Original article (Full-text)  | Erick Suazo-Zepeda et al. | Thorax 2026; aop:10.1136/thorax-2025-223372

Data are available upon reasonable request. Data are available upon reasonable request. Data and code are available on request from ES-Z at e.suazo.zepeda@umcg.nl. https://creativecommons.org/licenses/by-nc/4.0/...

Does Robotic Surgery Offer Advantages Over Thoracoscopic Surgery for Patients Undergoing Wedge Resection for Non-Small Cell Lung Cancer?
Lung
 1 min.

 Published on 28/04/2026 |  Original article (Full-text)  | Grace Ha et al. | European journal of cardio-thoracic surgery. Volume 68(3).

Wedge resection by video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracoscopic surgery (RATS) are minimally invasive techniques commonly used in non-small cell lung cancer management. Although RATS has been increasingly adopted for anatomical lung resections, it is unclear whether...